Loading clinical trials...
Loading clinical trials...
This long-term follow-up study will permit continued device use for participants of the parent study (NCT06677151). During study participation the study team will stay in contact with participants as necessary. Additionally, patients will undergo clinical follow-up as needed with their physician(s). At 12 months, participants will complete sleep questionnaires as part of this long-term follow-up period.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Michigan Medicine
Ann Arbor, Michigan, United States
University of Michigan
Ann Arbor, Michigan, United States
Start Date
October 21, 2025
Primary Completion Date
September 1, 2027
Completion Date
September 1, 2027
Last Updated
November 6, 2025
20
ESTIMATED participants
nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device
DEVICE
Lead Sponsor
University of Michigan
Collaborators
NCT07446634
NCT05497180
NCT04712656
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions